AGP Executive Report
Last update: 4 minutes agoDiagnostics: Siemens Healthineers has begun separating its diagnostics business, which it plans to rename Olyrian Diagnostics ahead of a possible sale. The process is expected to run until mid-2028 as the unit struggles with weaker demand in China. Vaccination Access: Germany is set to make COVID-19 vaccinations paid for most people, a change that could affect access. Healthcare Access: A study highlights continuing barriers to healthcare and health insurance in Germany. Cancer Research: German drugmaker Boehringer Ingelheim has struck a deal with China’s Sino Biopharm covering six cancer programs, with payments potentially reaching $7 billion. Health Risks: Climate change is reshaping Europe’s disease map, raising questions about how health systems prepare for shifting risks. Emergency Care: Siemens and Lufthansa Technik are planning a medical train for military evacuations and civilian disasters.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.